Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2024 09:34 ET | Source: Research and Markets

Acute Graft-Versus-Host Disease Pipeline Research 2024 Featuring MaaT Pharma, Medac, CSL Behring, Humanigen, Ironwood Pharmaceuticals, ReAlta Life Sciences, Roche, and Incyte

Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Acute Graft-Versus-Host Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Acute...
May 28, 2024 06:38 ET | Source: Research and Markets

Graft versus Host Disease (GvHD) Pipeline Insights Report, 2024: Reveals 60+ Companies Engaged in Advancing 65+ Pipeline Drugs

Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Graft versus host disease - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth look...
March 05, 2024 03:30 ET | Source: Research and Markets

Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report 2024

Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
February 28, 2024 11:05 ET | Source: Research and Markets

US HUMIRA Market Projected for Extensive Growth by 2032 in Noninfectious Autoimmune Uveitis Sector

Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "US HUMIRA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful analysis...
January 26, 2024 09:10 ET | Source: Research and Markets

Global Graft Versus Host Disease (GvHD) Treatment Market Forecast, 2028: High Treatment Costs and Infection Risks Prompt Focus on Predictive Biomarkers and Balanced Immunosuppression in Healthcare

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
January 24, 2024 12:56 ET | Source: Research and Markets

Graft vs. Host Disease Comprehensive 2032 Forecast Reveals Escalating Patient Populations in the 7MM

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This detailed analysis...
November 22, 2023 09:08 ET | Source: Research and Markets

Liposomal Cyclosporine A Emerging Drug Insights and Market Forecasts, 2017-2023 & 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report...
September 13, 2023 06:54 ET | Source: Research and Markets

Global Graft Versus Host Disease Treatment Market 2023-2030: Monoclonal Antibodies Lead Surge in Graft Versus Host Disease Treatment Market, Monitored by Comprehensive Vendor Analysis

Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
February 22, 2023 09:33 ET | Source: Research and Markets

Adalimumab Global Market Report 2022: Rising Prevalence of Arthritis and Clinical Trials to Spur Growth

Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By...
January 11, 2023 04:48 ET | Source: Research and Markets

Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector

Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...